Clinical trials: Lumbosacral Radiculopathy
Lumbosacral Radiculopathy
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
This is a long-term, 3-year, follow-up study for patients completing the KS-GIG-001-01 Study
- Trial name
- NCT05613569
- Testing
- KLS-2031
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Kolon Life Science
Lumbosacral Radiculopathy, Lumbar Radiculopathy
Platelet Lysate vs Saline for Lumbosacral Radiculopathy
This is a randomized trial to evaluate and compare platelet lysate epidural injection to saline epidural injection for the treatment of lumbar radiculopathy (sciatica).
- Trial name
- NCT06924853
- Testing
- Platelet lysate, Saline control
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- Regenexx, LLC
Painful Lumbosacral Radiculopathy
Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)
The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.
- Trial name
- NCT06176196
- Testing
- VX-548
- Where
- 54 sites in United States
- Volunteers
- 218 people
- Sponsor
- Vertex Pharmaceuticals Incorporated
Neuropathic Pain From Lumbosacral Radiculopathy
Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Escalating single-dose design study to determine the safety, tolerability, and analgesic activity of KLS-2031
- Trial name
- NCT04238793
- Testing
- KLS-2031
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Kolon Life Science
Lumbosacral Radicular Pain
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain.
- Trial name
- NCT03372161
- Testing
- SP-102
- Where
- 37 sites in United States
- Volunteers
- 401 people
- Sponsor
- Scilex Pharmaceuticals, Inc.
Lumbosacral Radiculopathy
Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
The study is a randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy.
- Trial name
- NCT01561027
- Testing
- CNV1014802
- Where
- 12 sites in Czechia, Denmark and 2 more
- Volunteers
- 82 people
- Sponsor
- Biogen
Pain, Neuropathic
Efficacy Study in Lumbosacral Radiculopathy
This study will be a double-blind, placebo-controlled, parallel group study. After enrolment and initial assessments, subjects will receive 35 days of study medication.
- Trial name
- NCT01110057
- Testing
- GS856553
- Where
- 17 sites in Denmark, France and 3 more
- Volunteers
- 142 people
- Sponsor
- GlaxoSmithKline
Lumbosacral Radiculopathy
Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain
The goal of this clinical trial is to evaluate if the drug candidate AFA-281 works to treat chronic low back and leg pain caused by painful lumbosacral radiculopathy (PLSR) in adults.
- Trial name
- NCT06649747
- Testing
- AFA-281
- Volunteers
- 408 people
- Sponsor
- Afasci Inc
Radiculopathy Lumbar, Degenerative Lumbar Disc Disease
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes
The goal of this clinical trial is to assess the safety and effectiveness of the study device, CORUS-LX, as an adjunct to lumbar interbody fusion, when used in combination with pedicle screw and rod constructs for the treatment…
- Trial name
- ILIF (NCT07222787)
- Testing
- Supplemental Posterior Fusion with Study Device, Supplemental Posterior Fusion with Standard Technique
- Where
- 12 sites in United States
- Volunteers
- 250 people
- Sponsor
- Providence Medical Technology, Inc.
Lumbosacral Radicular Pain
A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102
This is an open-label, single-arm, repeat dose study to characterize the pharmacodynamics and safety/tolerability of SP-102 administered by epidural injection.
- Trial name
- NCT03613662
- Testing
- SP-102
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- Semnur Pharmaceuticals, Inc.
Lumbosacral Radiculopathy
Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain
- Trial name
- NCT04778592
- Testing
- ETX-018810
- Where
- 24 sites in United States
- Volunteers
- 149 people
- Sponsor
- Eliem Therapeutics (UK) Ltd.
Lumbosacral Radiculopathy
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with…
- Trial name
- EXPAND (NCT06956014)
- Testing
- VER-01
- Where
- 23 sites in United States
- Volunteers
- 810 people
- Sponsor
- Vertanical GmbH
Lumbosacral Radiculopathy
Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
This study will compare Z160 and placebo in patients with Lumbosacral Radiculopathy for safety and efficacy for a period of 6 weeks.
- Trial name
- NCT01655849
- Testing
- z160
- Where
- 23 sites in United States
- Volunteers
- 141 people
- Sponsor
- Zalicus
Lumbosacral Radiculopathy
Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the…
- Trial name
- RePRIEVE-CM (NCT03727100)
- Testing
- Clonidine Micropellets
- Where
- 33 sites in United States
- Volunteers
- 207 people
- Sponsor
- Sollis Therapeutics, Inc.
Lumbosacral Radiculopathy
Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy
The primary objective of the study is to evaluate the efficacy of two dose regimens of BIIB074 on neuropathic pain in participants with pain from lumbosacral radiculopathy (PLSR).
- Trial name
- RELAY-1 (NCT02935608)
- Testing
- BIIB074
- Where
- 56 sites in Austria, Belgium and 12 more
- Volunteers
- 502 people
- Sponsor
- Biogen
Neuropathic Pain From Lumbosacral Radiculopathy
Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074
The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB074 in participants with neuropathic Pain From Lumbosacral Radiculopathy (PLSR).
- Trial name
- RELAY-1 Extend (NCT02957617)
- Testing
- BIIB074
- Where
- 51 sites in Austria, Belgium and 12 more
- Volunteers
- 302 people
- Sponsor
- Biogen
Radiculopathy Lumbar, Radiculopathy Sacral
Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy
This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating lumbosacral radiculopathy.
- Conditions
- Radiculopathy Lumbar, Radiculopathy Sacral, Radiculopathy Multiple Sites
- Trial name
- NCT06421558
- Testing
- Neubie Direct Current Electrical Stimulation Device, Transcutaneous Electrical Stimulation
- Where
- 16 sites in United States
- Volunteers
- 150 people
- Sponsor
- NeuFit - Neurological Fitness and Education
Lumbar Spine Degeneration
INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine
This investigation will provide safety and effectiveness information on the use of INFUSE® Bone Graft with the CAPSTONE® Spinal System and CD HORIZON® Spinal System with a Transforaminal Lumbar Interbody Fusion (TLIF) surgical…
- Trial name
- TLIF (NCT01415908)
- Testing
- INFUSE Bone Graft, Iliac Crest Bone Graft
- Where
- 5 sites in United States
- Volunteers
- 15 people
- Sponsor
- Medtronic Spinal and Biologics
Sciatica, Lumbosacral Radiculopathy
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
The primary objectives of this clinical trial are to investigate the pharmacokinetics and safety of MDT-15 pellets in escalating sequential doses administered to different cohorts.
- Trial name
- NCT01917825
- Testing
- MDT-15
- Where
- 6 sites in United States
- Volunteers
- 54 people
- Sponsor
- Medtronic Spinal and Biologics
Lumbosacral Radiculopathy
Long-Term Follow-up Safety of Clonidine Micropellets
Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months post injection.
- Trial name
- RePRIEVE-CM-LT (NCT03776318)
- Testing
- Long-Term Safety Follow-up
- Where
- 25 sites in United States
- Volunteers
- 100 people
- Sponsor
- Sollis Therapeutics, Inc.